Objective Universal screening for cytomegalovirus (CMV) infection in pregnancy is not
recommended in most countries. One of the major deterrents is the lack of effective prenatal …

Objective Recent studies have shown that a dosage of 8 g/d of oral valacyclovir reduces
substantially the vertical transmission rate of cytomegalovirus in women with primary …

BACKGROUND Valacyclovir is the only treatment demonstrated to be effective for the
prevention of vertical transmission of cytomegalovirus within a clinical randomized, placebo …

Objective Congenital cytomegalovirus (CMV) infection is the leading cause of non‐genetic
hearing and neurological deficits. The aim of our study was to evaluate the efficacy and …

Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0.64%
global prevalence and a 17–20% chance of serious long-term effects in children. Since the …

Viral infections during pregnancy are associated with significant adverse perinatal and fetal
outcomes. Pregnancy is a unique immunologic and physiologic state, which can influence …

The present review article presents the key messages of the 8th Workshop on Paediatric
Virology organised virtually by the Institute of Paediatric Virology based on the island of …

Cytomegalovirus (CMV) is the most common cause of congenital infections in developed
countries because is capable of infecting the fetus after both primary and recurrent maternal …

Congenital cytomegalovirus (cCMV) infection is the most common congenital infection, with
an estimated incidence of approximately one in 200 infants in high-income settings …

Background Congenital cytomegalovirus (cCMV) is the most common congenital infection
worldwide. cCMV can lead to severe long‐term sequelae, including neurological impairment …